Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,741 JPY | -3.96% | +1.14% | 0.00% |
04:43pm | AEON Biopharma Shares Slump Pre-Bell After Failed Chronic Migraine Phase 2 Trial | MT |
02:40pm | Kelso raises stake in NCC; Transense joins project | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.11B | |
+11.87% | 325B | |
+11.35% | 73.15B | |
-6.58% | 65.82B | |
+0.53% | 30.13B | |
+21.39% | 23.36B | |
+9.66% | 14.31B | |
+12.14% | 10B | |
-6.82% | 6.48B | |
+0.88% | 4.58B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- Actinogen Doses First Patient in Phase 2b Alzheimer’s Disease Trial; Shares Rally 16%